{
  "id": "CD015536.PUB2",
  "draft": "Is entecavir effective and safe for children and adults with chronic hepatitis B compared to no treatment or a placebo?\n\nWe looked at the benefits and harms of entecavir for children and adults with chronic hepatitis B. We wanted to know if entecavir is better than no treatment or a placebo in reducing serious health problems and improving quality of life.\n\n- Entecavir may have benefits and unwanted effects for people with chronic hepatitis B, but we are not sure how it compares to no treatment or a placebo in terms of death from any cause and serious harmful effects.\n- We found very low-certainty evidence, meaning we are very uncertain about the results, and more research is needed to fully understand the effects of entecavir.\n- Future research should focus on addressing the limitations of current evidence, including the lack of data on quality of life and the need for longer-term follow-up.\n\nWhat is chronic hepatitis B and why is it a problem?\nChronic hepatitis B is a major public health concern worldwide. It is a liver infection caused by the hepatitis B virus that can lead to serious health problems, including liver damage, liver cancer, and death. Entecavir is one of the antiviral therapy options used to treat chronic hepatitis B.\n\nWhat did the review authors want to find out?\nThe review authors wanted to evaluate the benefits and harms of entecavir compared to no treatment or placebo in children and adults with chronic hepatitis B. They aimed to find out whether entecavir is effective in reducing the risk of serious health problems, such as death from any cause and serious harmful effects, and improving quality of life.\n\nWhat did we find?\nWe found 22 studies that involved 2940 people with chronic hepatitis B. The studies were conducted over a period of 5 weeks to 228 weeks. Entecavir may reduce or have little to no effect on the proportion of people with serious harmful effects, but we are very uncertain about the results. It is unclear if entecavir has an effect on death from any cause. There is a lack of data on quality of life.\n\nWhat are the limitations of the evidence?\nThe limitations of the evidence are that participants may have known which treatment they received, not all studies reported all outcomes of interest, and the studies were very small.\n\nHow up-to-date is the evidence?\nThe evidence is up to date to July 2024.",
  "metrics": [
    {
      "linguistic_evaluation": {
        "words": {
          "value": 424,
          "rating": "within_limit",
          "direction": null,
          "feedback": null
        },
        "sentences": {
          "value": 21,
          "rating": "info",
          "direction": null,
          "feedback": null
        },
        "words_per_sentence": {
          "value": 20.19047619047619,
          "rating": "P50",
          "direction": "lower_better",
          "feedback": null
        },
        "passive_voice": {
          "value": 7,
          "rating": "P25",
          "direction": "lower_better",
          "feedback": null
        },
        "active_voice": {
          "value": 34,
          "rating": "P50",
          "direction": "higher_better",
          "feedback": null
        },
        "pronouns": {
          "value": 21,
          "rating": "P75",
          "direction": "higher_better",
          "feedback": null
        },
        "nominalization": {
          "value": 13,
          "rating": "P50",
          "direction": "lower_better",
          "feedback": null
        },
        "nouns": {
          "value": 118,
          "rating": "P75",
          "direction": "lower_better",
          "feedback": null
        },
        "flesch_reading_ease": {
          "value": 55.65062893081762,
          "rating": "P75",
          "direction": "higher_better",
          "feedback": null
        },
        "flesch_kincaid_grade": {
          "value": 10.513059299191376,
          "rating": "P25",
          "direction": "lower_better",
          "feedback": null
        },
        "automated_readability_index": {
          "value": 9.749153189577719,
          "rating": "P25",
          "direction": "lower_better",
          "feedback": null
        },
        "coleman_liau_index": {
          "value": 9.055283018867922,
          "rating": "P25",
          "direction": "lower_better",
          "feedback": null
        },
        "gunning_fog_index": {
          "value": 15.340341419586702,
          "rating": "P25",
          "direction": "lower_better",
          "feedback": null
        },
        "lix": {
          "value": 48.25651392632525,
          "rating": "P25",
          "direction": "lower_better",
          "feedback": null
        },
        "rix": {
          "value": 5.666666666666667,
          "rating": "P25",
          "direction": "lower_better",
          "feedback": null
        },
        "smog_index": {
          "value": 11.246211251235321,
          "rating": "P50",
          "direction": "lower_better",
          "feedback": null
        },
        "dale_chall_readability": {
          "value": 6.587532524707997,
          "rating": "P25",
          "direction": "lower_better",
          "feedback": null
        },
        "complex_words_dc": {
          "value": 150,
          "rating": "P50",
          "direction": "lower_better",
          "feedback": null
        },
        "complex_words": {
          "value": 77,
          "rating": "P50",
          "direction": "lower_better",
          "feedback": null
        },
        "long_words": {
          "value": 119,
          "rating": "P50",
          "direction": "lower_better",
          "feedback": null
        }
      },
      "word_count_status": {
        "word_count": 424,
        "limit": 850,
        "status": "within_limit",
        "message": "Word count: 424 ✓ WITHIN LIMIT (≤850 words)"
      },
      "summary": {
        "P25_count": 8,
        "P50_count": 7,
        "P75_count": 3,
        "P90_count": 0,
        "P10_count": 0,
        "BEYOND_P90_count": 0,
        "BELOW_P10_count": 0,
        "total_evaluated": 18,
        "P25_percentage": 44.44444444444444,
        "P50_percentage": 38.88888888888889,
        "P75_percentage": 16.666666666666664,
        "P90_percentage": 0,
        "P10_percentage": 0,
        "BEYOND_P90_percentage": 0,
        "BELOW_P10_percentage": 0,
        "best_quartile_rate": 61.111111111111114,
        "overall_assessment": "HIGHLY CONFORMS TO TYPICAL PLS PATTERNS"
      }
    }
  ],
  "evaluation": [
    {
      "grade": "NOT_APPROVED",
      "feedback": "This draft is not approved. It fails a critical check because it is missing the required 'Methods' section, which explains how the review was conducted. Additionally, several key phrases need to be clearer for a patient audience.\n\nHere are the top 3 improvements needed:\n\n1. **Add the missing 'Methods' section.** A PLS must explain how the authors arrived at their conclusions. Please add a new section with a heading like 'How did we conduct this review?' and include the methods summary from the source material: 'We searched for studies comparing entecavir with no treatment or placebo in people with chronic hepatitis B, summarized their results, and rated our confidence in the evidence.'\n\n2. **Clarify the main finding on harmful effects.** The current wording is confusing and could be misinterpreted by a reader.\n    *   **Current sentence:** 'Entecavir may reduce or have little to no effect on the proportion of people with serious harmful effects, but we are very uncertain about the results.'\n    *   **Problem:** The phrase 'may reduce or have little to no effect' is vague and combines two different potential outcomes. The most important point for the reader is the high level of uncertainty.\n    *   **Suggested rewrite:** 'We are very uncertain if entecavir reduces serious harmful effects compared to no treatment or a placebo. The evidence is not strong enough to be sure.'\n\n3. **Use consistent terminology for outcomes.** The summary uses 'serious health problems' and 'serious harmful effects' to describe the same concept. This can be confusing for readers.\n    *   **Problem:** Inconsistent terms make the text harder to follow.\n    *   **Suggestion:** Please choose one patient-friendly term, such as 'serious harmful effects', and use it consistently throughout the summary, especially in the 'Aims' and 'Results' sections.",
      "pls_evaluation_summary": "The linguistic analysis shows the draft highly conforms to the statistical patterns of a typical Plain Language Summary. All 18 metrics fall within the median or best quartile ranges, indicating strong performance in areas like readability (Flesch-Kincaid Grade Level: 10.5), sentence length (20 words on average), and use of active voice. Despite this strong statistical profile, the summary is not approved due to a critical structural omission and specific clarity issues that require editorial attention."
    }
  ]
}